According to AquaBounty's latest financial reports and stock price the company's current Operating Margin is -903.96%. At the end of 2021 the company had an Operating Margin of -1,900.07%.
Year | Operating Margin | Change |
---|---|---|
2021 | -1,900.07% | -85.21% |
2020 | -12,846.31% | 81.35% |
2019 | -7,083.53% | -42.33% |
2018 | -12,283.84% | -29.31% |
2017 | -17,377.99% | |
2008 | -11,705.13% | 380% |
2007 | -2,438.57% | -31.67% |
2006 | -3,568.70% | 270.05% |
2005 | -964.38% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Organovo ONVO | -591.52% | -34.56% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -129.00% | -85.73% | ๐ฌ๐ง UK |
Novavax NVAX | -149.57% | -83.45% | ๐บ๐ธ USA |
Novocure
NVCR | -37.52% | -95.85% | Jersey |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.